Department of Urology, Loyola University Medical Center, Maywood, IL, 60153, USA.
Department of Urology, University of Michigan, Ann Arbor, MI, USA.
World J Urol. 2020 Nov;38(11):2963-2969. doi: 10.1007/s00345-020-03093-3. Epub 2020 Jan 25.
Percutaneous nephrolithotomy (PCNL) is performed commonly in patients with large kidney stones, but the management of their postoperative pain presents a major challenge. While it is not routinely performed in PCNL patients, paravertebral block (PVB) has been described as an effective strategy for pain control after various non-urologic surgeries. This trial aims to assess the effect of paravertebral blockade on intraoperative and postoperative opioid use as well as postoperative pain control in patients undergoing PCNL.
This was a prospective, randomized, double-blind, placebo-controlled study. Patients who consented to participate were randomly assigned to undergo either PVB or a placebo intervention preoperatively. The patient, surgeon, and anesthesia team were all blinded to the randomization. The outcome parameters were intraoperative opioid requirement, postoperative visual analog scale (VAS) pain scores, postoperative opioid use, and postoperative antiemetic use.
23 patients were enrolled in each arm of the study, and the two groups had no significant differences in baseline demographic or clinical characteristics. Patients in the PVB group had significantly lower intraoperative opioid use, postoperative opioid use, frequency of opioid use, and antiemetic. Patients in the PVB group also had lower postoperative VAS pain scores. There were no patients who suffered from complications attributable to PVB.
The results of this randomized, double-blind, placebo-controlled trial suggest that PVB should be considered an effective strategy to reduce opioid requirement and improve pain control for patients undergoing PCNL.
经皮肾镜碎石术(PCNL)常用于治疗大肾结石患者,但术后疼痛管理仍是一个主要挑战。虽然在 PCNL 患者中不常规进行,但椎旁阻滞(PVB)已被描述为各种非泌尿科手术后控制疼痛的有效策略。本试验旨在评估椎旁阻滞对 PCNL 患者术中及术后阿片类药物使用以及术后疼痛控制的影响。
这是一项前瞻性、随机、双盲、安慰剂对照研究。同意参与的患者被随机分配接受术前椎旁阻滞或安慰剂干预。患者、外科医生和麻醉团队均对随机分组不知情。结局参数为术中阿片类药物需求、术后视觉模拟量表(VAS)疼痛评分、术后阿片类药物使用和术后止吐药使用。
每组 23 例患者入组,两组患者的基线人口统计学和临床特征无显著差异。PVB 组患者术中阿片类药物使用、术后阿片类药物使用、阿片类药物使用频率和止吐药使用明显减少。PVB 组患者术后 VAS 疼痛评分也较低。没有患者因椎旁阻滞而出现并发症。
这项随机、双盲、安慰剂对照试验的结果表明,椎旁阻滞应被视为一种有效策略,可减少 PCNL 患者的阿片类药物需求并改善疼痛控制。